As the festive season approaches, we would like to thank our clients and industry colleagues for a successful year. We wish everyone a season filled with warmth, relaxation and joy. Happy Holidays and a peaceful and prosperous New Year! 💝
Medfiles
Pharmaceutical Manufacturing
Kuopio, Eastern Finland 6 539 followers
R&D | Analytics | Clinical Trials | Regulatory Affairs | Pharmacovigilance – Medicines | MD & IVD | Food & Feed
About us
Medfiles is an international company that offers expert services and support to its clients on their path of product commercialisation. With our comprehensive service solutions and array of services related to human and veterinary medicines, medical devices, in vitro diagnostic devices and food & feed and cosmetic products, we help to secure a healthier tomorrow together with our clients. Our one-stop service package offers a fluent and flexible solution for our clients’ outsourcing needs, for businesses of all sizes. We offer a complete range of product development process, starting with pharmaceutical development with quality control laboratory analyses (chemical and microbiological), implementing clinical trials and dealing with regulatory affairs (e.g. marketing authorization, pharmacovigilance). Our client base is varied but includes both small and large Pharma, Biotech, Medical device, Veterinary, Public health authorities, CMO & CROs. We serve companies globally. Our core competence is in the European market but we are also continuously strengthening our expertise in other market areas in order to increase our international presence as a premium quality service provider and CRO. To work with Medfiles, means you work with a company that has over 35 years of experience and a long list of international clients & references to prove its worth. With a team of about 180 experts, Medfiles solidly supports its clients through an offering of services that meets the ever-evolving requirements of the healthcare industry. Our contribution to bringing better and safer healthcare solutions for patients and consumers is the priority and the driving force behind our decision-making.
- Sivusto
-
https://medfilesgroup.com/
External link for Medfiles
- Toimiala
- Pharmaceutical Manufacturing
- Yrityksen koko
- 51–200 työntekijää
- Päätoimipaikka
- Kuopio, Eastern Finland
- Tyyppi
- Public Company
- Perustettu
- 1987
- Erityisosaaminen
Sijainnit
Työntekijät Medfiles
Päivitykset
-
Haemme lääketurvatiimiimme lääketurva-asiantuntijaa (Pharmacovigilance & Medical Information Expert). 🔍 Tarjolla on monipuolinen asiantuntijatehtävä kansainvälisessä, joustavassa ja innostavassa tiimissä. Tehtäviisi kuuluvat ihmis- ja eläinlääkevalmisteiden lääketurvallisuuteen sekä lääkinnällisten laitteiden turvallisuuteen liittyvät tehtävät. Voit sijoittua Vantaan, Tampereen tai Kuopion toimistollemme, ja joustava hybridityöskentely on mahdollista. 𝐊𝐢𝐢𝐧𝐧𝐨𝐬𝐭𝐮𝐢𝐭𝐤𝐨? Lue lisää tehtävästä ja hae paikkaa 12.1. mennessä. Toimi nopeasti – täytämme paikan heti sopivan henkilön löydyttyä! ➡ https://lnkd.in/eBT47Tqx #workatmedfiles #lääketurva #lääketurvallisuus #rekry
-
Meet Ingrid Hagberg, our toxicology reinforcement from Canada! 💎 Ingrid has worked for Health Canada and the Canadian Food Inspection Agency for many years and has a strong background in food toxicology and risk assessment. At Medfiles, Ingrid's work covers a wide range of areas including toxicology, risk assessment and regulatory affairs for food and feed. Her diverse career has also given her a strong background in regulatory compliance in Canada, the US and the EU. Read more about Ingrid's work and expertise ➡️ https://lnkd.in/eBdp8VP5 #workatmedfiles #toxicology #riskassessment #regulatorycompliance #food
-
💊 The safety of food supplements is a hot topic in the EU. Recently, the Working Group “Food Supplements” of Heads of Food Safety Agencies gathered a list of 117 substances with potential health risks. While harmonised legislation covers vitamins, minerals, and authorised novel foods, the "other substances" category requires unique knowledge of the target market. Key points for compliance of other substances in food supplements involve: 🔹Around a dozen substances, including e.g. tryptophan and piperine, are recommended to be prioritised in a potential evaluation process by EFSA. 🔹National approaches vary across the Nordics – for instance, melatonin is regulated differently in Finland, Sweden, and Norway. 🔹Compliance involves both EU-level and national requirements, and oftentimes, both qualitative and quantitative aspects are needed for determining the regulatory status. Read the full blog post on compliance of other substances used in food supplements ➡️ https://lnkd.in/dhZG7j8Q #foodsupplements #foodregulatory #foodsafety #foodingredient
-
Not sure how to successfully submit your clinical trial application via the CTIS portal? Our practical guide is created to provide clarity and support. It covers the following topics: ✔ What is the CTIS portal ✔ EMA system registrations & activations ✔ Submission procedure ✔ Required data and documents ✔ Requests for information (RFIs) ✔ Substantial modifications ✔ Product management ✔ Safety reporting Download for free: https://lnkd.in/gwWDcEKi #CTIS #CTISportal #clinicaltrials #clinicalresearch
-
Determining whether a food ingredient is 𝐧𝐨𝐯𝐞𝐥 𝐨𝐫 𝐧𝐨𝐭 can be challenging. If the status is unclear, companies can submit 𝐚 𝐜𝐨𝐧𝐬𝐮𝐥𝐭𝐚𝐭𝐢𝐨𝐧 𝐫𝐞𝐪𝐮𝐞𝐬𝐭 to an EU Member State or to the UK. 💡Since 2018, more than 110 consultation conclusions have been issued in the EU, with around 40 % classified as not novel. A consultation request can save your company time, resources and the lengthy novel food authorisation process, making it a valuable option to consider. Read our blog to learn more about the process ➡️ https://lnkd.in/ebTKKbqv P.S. Medfiles experts have years of experience with novel foods, including 10 submitted consultation requests, and are happy to help! #novelfood #consultationrequest #foodingredient #foodregulation
-
In 2021, WellO2 Oy started their first clinical study to investigate the benefits of the device for people with asthma. That’s when WellO2 started working with Medfiles. The clinical investigation was successfully completed in 2022. ✅ Katri Lindberg, Respiratory Specialist at WellO2, says they relied heavily on Medfiles’ help. Medfiles helped with applying for the research permit and designing the required documents, trained the study site staff, carried out the monitoring visits at the study site and helped to ensure patient safety. In addition to managing the project as a whole and coordinating different parts of it, Medfiles also helped WellO2 with the small details and practicalities. Read more about how Katri describes the cooperation ➡ https://lnkd.in/e6_uM9Ey #clinicalinvestigation #clinicalstudy #clinicaltrials #medicaldevice
-
🌱 The current global changes have many effects on feed products and the entire feed sector, including: • challenges in agriculture • development of alternative protein sources and green development • changes in regulatory requirements. Read our blog for our views on the recent developments in the feed sector ➡️ https://lnkd.in/eAgbF_Ei #animalfeed #feedregulatory #agriculture #feedindustry
Animal feed trends in the changing world
https://medfilesgroup.com
-
What should be included in the marketing authorisation application in the EU? 💊 The application must be comprehensive and contain all the necessary documentation and data that regulatory authorities require to evaluate the safety, efficacy, and quality of the medicinal product. Each section of the application is critical to the overall evaluation of the product by regulatory authorities. Read about the key components included in the dossier ⬇ #marketingauthorization #regulatoryaffairs #pharmaceuticals #pharmacovigilance
How to obtain a marketing authorisation in the EU – requirements and approval process for medicinal products
https://medfilesgroup.com
-
In May 2024, new Veterinary Medicines Regulations (VMR), as amended, came into effect in GB. 🇬🇧 Periodic Safety Update Reports (PSURs), Adverse Event Reporting and Detailed Description of the Pharmacovigilance System (DDPS) have seen the most substantial changes. These often align with the EU Veterinary Medicines Regulation 2019/6, but our Veterinary Pharmacovigilance Unit has taken care to ensure compliance in both the EU and GB is maintained. A brief glimpse of some implementation changes we can support our clients with: ▪ Updating SOPs to ensure 30-day UK Adverse Event reporting compliance ▪ Conduct PSMF summary submissions to VMD during the DDPS to Pharmacovigilance System Master Files (PSMFs) change, ensuring full PSMFs are available for inspections. ▪ Make reviews of existing PSUR DLPs to ensure smooth transition to the new Signal Management and Annual Benefit-Risk Report System (BRSR). The area of Veterinary Pharmacovigilance is ever-changing and at Medfiles, as both PV experts and animal lovers, we are excited to be part of both small and large-scale projects related to the improvement of companion and livestock health. With six months left before the transition deadline, if you need assistance in reaching compliance with the new GB VMR, as amended, our animal health PV team is happy to help. Read about the EU Veterinary Medicines Regulation 2019/6 3 years on ➡ https://lnkd.in/eF39QjK9 Read about our post-authorisation PV services for veterinary medicines ➡ https://lnkd.in/dJNtpeR2 #pharmacovigilance #PV #drugsafety #animalhealth #veterinarymedicine